Skip to main content
Top
Literature
2.
go back to reference Elizalde JI, Gómez J, Panés J, Lozano M, et al. Platelet activation in mice and human Helicobacter pylori infection. J Clin Investig. 1997;100:996–1005.CrossRefPubMedPubMedCentral Elizalde JI, Gómez J, Panés J, Lozano M, et al. Platelet activation in mice and human Helicobacter pylori infection. J Clin Investig. 1997;100:996–1005.CrossRefPubMedPubMedCentral
3.
go back to reference Byrne MF, Kerrigan SW, Corcoran PA, Atherton JC, et al. Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation. Gastroenterology. 2003;124:1846–1854.CrossRefPubMed Byrne MF, Kerrigan SW, Corcoran PA, Atherton JC, et al. Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation. Gastroenterology. 2003;124:1846–1854.CrossRefPubMed
4.
go back to reference Innocenti M, Thoreson AC, Ferrero RL, Strömberg E, et al. Helicobacter pylori-induced activation of human endothelial cells. Infect Immun. 2002;70:4581–4590.CrossRefPubMedPubMedCentral Innocenti M, Thoreson AC, Ferrero RL, Strömberg E, et al. Helicobacter pylori-induced activation of human endothelial cells. Infect Immun. 2002;70:4581–4590.CrossRefPubMedPubMedCentral
5.
go back to reference Dundon WG, Nishioka H, Polenghi A, Papinutto E, et al. The neutrophil-activating protein of Helicobacter pylori. Int J Med Microbiol. 2002;291:545–550.CrossRefPubMed Dundon WG, Nishioka H, Polenghi A, Papinutto E, et al. The neutrophil-activating protein of Helicobacter pylori. Int J Med Microbiol. 2002;291:545–550.CrossRefPubMed
6.
go back to reference Kutuk O, Basaga H. Inflammation meets oxidation: NF-κB as a mediator of initial lesion development in atherosclerosis. Trends Mol Med. 2003;9:549–557.CrossRefPubMed Kutuk O, Basaga H. Inflammation meets oxidation: NF-κB as a mediator of initial lesion development in atherosclerosis. Trends Mol Med. 2003;9:549–557.CrossRefPubMed
8.
go back to reference Consolazio A, Borgia MC, Ferro D, Iacopini F, et al. Increased thrombin generation and circulating levels of tumour necrosis factor-alpha in patients with chronic Helicobacter pylori-positive gastritis. Aliment Pharmacol Ther. 2004;20:289–294.CrossRefPubMed Consolazio A, Borgia MC, Ferro D, Iacopini F, et al. Increased thrombin generation and circulating levels of tumour necrosis factor-alpha in patients with chronic Helicobacter pylori-positive gastritis. Aliment Pharmacol Ther. 2004;20:289–294.CrossRefPubMed
10.
go back to reference Leone N, Pellicano R, Brunello M, Berrutti M, et al. Helicobacter pylori seroprevalence in patients with cirrhosis of the liver and hepatocellular carcinoma. Cancer Detect Prev. 2003;27:494–497.CrossRefPubMed Leone N, Pellicano R, Brunello M, Berrutti M, et al. Helicobacter pylori seroprevalence in patients with cirrhosis of the liver and hepatocellular carcinoma. Cancer Detect Prev. 2003;27:494–497.CrossRefPubMed
11.
go back to reference Wang L, Zollinger T, Zhang J. Association between Helicobacter pylori infection and liver cancer mortality in 67 rural Chinese counties. Cancer Causes Control. 2013;24:1331–1337.CrossRefPubMed Wang L, Zollinger T, Zhang J. Association between Helicobacter pylori infection and liver cancer mortality in 67 rural Chinese counties. Cancer Causes Control. 2013;24:1331–1337.CrossRefPubMed
Metadata
Title
Hepatic Encephalopathy and Helicobacter pylori
Authors
Antonio Ponzetto
Dino Vaira
Publication date
01-05-2018
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 5/2018
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5038-z

Other articles of this Issue 5/2018

Digestive Diseases and Sciences 5/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.